Glycodeoxycholic Acid
| Internal ID | 0d4d94b3-57bf-4d04-97a6-2ac1eb6f71b8 |
| Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Bile acids, alcohols and derivatives > Glycinated bile acids and derivatives |
| IUPAC Name | 2-[[(4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C26H43NO5/c1-15(4-9-23(30)27-14-24(31)32)19-7-8-20-18-6-5-16-12-17(28)10-11-25(16,2)21(18)13-22(29)26(19,20)3/h15-22,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16-,17-,18+,19-,20+,21+,22+,25+,26-/m1/s1 |
| InChI Key | WVULKSPCQVQLCU-BUXLTGKBSA-N |
| Popularity | 290 references in papers |
| Molecular Formula | C26H43NO5 |
| Molecular Weight | 449.60 g/mol |
| Exact Mass | 449.31412347 g/mol |
| Topological Polar Surface Area (TPSA) | 107.00 Ų |
| XlogP | 4.30 |
| Atomic LogP (AlogP) | 3.59 |
| H-Bond Acceptor | 4 |
| H-Bond Donor | 4 |
| Rotatable Bonds | 6 |
| Deoxycholylglycine |
| Glycodeoxycholate |
| 360-65-6 |
| Glycodesoxycholic acid |
| GDCA |
| Deoxycholic acid glycine conjugate |
| Deoxyglycocholic acid |
| Glycyldeoxycholic acid |
| CHEMBL258605 |
| CHEBI:27471 |
| There are more than 10 synonyms. If you wish to see them all click here. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9010 | 90.10% |
| Caco-2 | - | 0.8991 | 89.91% |
| Blood Brain Barrier | + | 0.5500 | 55.00% |
| Human oral bioavailability | - | 0.5571 | 55.71% |
| Subcellular localzation | Mitochondria | 0.7881 | 78.81% |
| OATP2B1 inhibitior | + | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8336 | 83.36% |
| OATP1B3 inhibitior | + | 0.9371 | 93.71% |
| MATE1 inhibitior | - | 0.9600 | 96.00% |
| OCT2 inhibitior | - | 0.8064 | 80.64% |
| BSEP inhibitior | + | 0.6213 | 62.13% |
| P-glycoprotein inhibitior | - | 0.5606 | 56.06% |
| P-glycoprotein substrate | + | 0.6542 | 65.42% |
| CYP3A4 substrate | + | 0.7251 | 72.51% |
| CYP2C9 substrate | + | 0.5320 | 53.20% |
| CYP2D6 substrate | - | 0.8412 | 84.12% |
| CYP3A4 inhibition | - | 0.8309 | 83.09% |
| CYP2C9 inhibition | - | 0.9071 | 90.71% |
| CYP2C19 inhibition | - | 0.9026 | 90.26% |
| CYP2D6 inhibition | - | 0.9231 | 92.31% |
| CYP1A2 inhibition | - | 0.9382 | 93.82% |
| CYP2C8 inhibition | - | 0.6612 | 66.12% |
| CYP inhibitory promiscuity | - | 0.8426 | 84.26% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.9800 | 98.00% |
| Carcinogenicity (trinary) | Non-required | 0.6707 | 67.07% |
| Eye corrosion | - | 0.9941 | 99.41% |
| Eye irritation | - | 0.9012 | 90.12% |
| Skin irritation | - | 0.7388 | 73.88% |
| Skin corrosion | - | 0.9552 | 95.52% |
| Ames mutagenesis | - | 0.5701 | 57.01% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.5260 | 52.60% |
| Micronuclear | + | 0.5100 | 51.00% |
| Hepatotoxicity | + | 0.5217 | 52.17% |
| skin sensitisation | - | 0.9078 | 90.78% |
| Respiratory toxicity | + | 0.7889 | 78.89% |
| Reproductive toxicity | + | 0.9000 | 90.00% |
| Mitochondrial toxicity | + | 0.7500 | 75.00% |
| Nephrotoxicity | - | 0.9216 | 92.16% |
| Acute Oral Toxicity (c) | III | 0.6594 | 65.94% |
| Estrogen receptor binding | - | 0.7766 | 77.66% |
| Androgen receptor binding | + | 0.7564 | 75.64% |
| Thyroid receptor binding | + | 0.7966 | 79.66% |
| Glucocorticoid receptor binding | + | 0.8032 | 80.32% |
| Aromatase binding | + | 0.7034 | 70.34% |
| PPAR gamma | + | 0.5556 | 55.56% |
| Honey bee toxicity | - | 0.7512 | 75.12% |
| Biodegradation | - | 0.6500 | 65.00% |
| Crustacea aquatic toxicity | - | 0.5500 | 55.00% |
| Fish aquatic toxicity | + | 0.9167 | 91.67% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 97.76% | 90.17% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 97.18% | 94.45% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 96.12% | 96.09% |
| CHEMBL2581 | P07339 | Cathepsin D | 95.15% | 98.95% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 93.49% | 85.31% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 92.90% | 98.10% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 92.66% | 95.00% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 91.76% | 91.11% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 88.93% | 90.71% |
| CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 | 88.35% | 88.81% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 88.32% | 91.19% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 87.53% | 98.05% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 87.37% | 94.45% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 86.88% | 97.09% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 86.52% | 100.00% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 86.51% | 96.00% |
| CHEMBL233 | P35372 | Mu opioid receptor | 86.46% | 97.93% |
| CHEMBL236 | P41143 | Delta opioid receptor | 86.25% | 99.35% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 85.86% | 96.38% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 85.83% | 95.89% |
| CHEMBL238 | Q01959 | Dopamine transporter | 85.18% | 95.88% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 84.86% | 96.03% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 84.82% | 100.00% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 84.76% | 99.17% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 84.59% | 99.23% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 84.44% | 82.69% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 83.93% | 97.86% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 83.57% | 98.77% |
| CHEMBL4681 | P42330 | Aldo-keto-reductase family 1 member C3 | 82.91% | 89.05% |
| CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 82.53% | 99.00% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 82.29% | 97.50% |
| CHEMBL4246 | P42680 | Tyrosine-protein kinase TEC | 81.52% | 82.05% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 81.07% | 96.33% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 81.04% | 96.47% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 80.65% | 96.67% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 80.62% | 94.33% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 80.59% | 93.56% |
| CHEMBL3921 | Q9Y251 | Heparanase | 80.56% | 94.00% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 80.32% | 93.00% |
| CHEMBL5028 | O14672 | ADAM10 | 80.29% | 97.50% |
| CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 80.16% | 96.77% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 3035026 |
| LOTUS | LTS0217717 |
| wikiData | Q5572601 |